Title:
DEZOCINE DERIVATIVE AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/156522
Kind Code:
A1
Abstract:
Provided are a dezocine derivative of formula I or a tautomer, optical isomer, oxynitride, solvate, pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutical composition comprising the same, a preparation method therefor, and a medical use thereof, the structure of the formula I is as follows:
Inventors:
SHAO LIMING (CN)
HU TAO (CN)
XU HAOYU (CN)
CHEN LINGWU (CN)
ZOU YIQUAN (CN)
CAI WEI (CN)
YANG XICHENG (CN)
LI HAODONG (CN)
XUE DENGQI (CN)
HU TAO (CN)
XU HAOYU (CN)
CHEN LINGWU (CN)
ZOU YIQUAN (CN)
CAI WEI (CN)
YANG XICHENG (CN)
LI HAODONG (CN)
XUE DENGQI (CN)
Application Number:
PCT/CN2020/074131
Publication Date:
August 06, 2020
Filing Date:
January 31, 2020
Export Citation:
Assignee:
YANGZIJIANG PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07C215/64; A61K31/135; A61P25/04; C07C217/58; C07C217/94
Domestic Patent References:
WO2018090982A1 | 2018-05-24 | |||
WO2018090982A1 | 2018-05-24 |
Foreign References:
CN1195344A | 1998-10-07 | |||
CN1195344A | 1998-10-07 | |||
CN1196053A | 1998-10-14 | |||
CN1196053A | 1998-10-14 | |||
US3976696A | 1976-08-24 | |||
US3976696A | 1976-08-24 | |||
US3979434A | 1976-09-07 | |||
US3979434A | 1976-09-07 | |||
US4034041A | 1977-07-05 | |||
CN109206385A | 2019-01-15 | |||
CN108285423A | 2018-07-17 | |||
CN201910106523A | 2019-02-02 |
Other References:
See also references of EP 3919472A4
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: